Recent Patents on Regenerative Medicine - Volume 4, Issue 3, 2014

Myocardial infarction results in loss of cardiac muscle and deficiency in cardiac performance. Likewise, peripheral artery disease can result in critical limb ischemia leading to reduced mobility, non-healing ulcers, gangrene and amputation. Both of these common conditions diminish quality of life and enhance risk of mortality. Successful advances in treatment have led to more people surviving incidences of myocardial infar Read More

Over the past 15 years, the development of magnesium (Mg)-based biodegradable materials has undergone considerable progress and has demonstrated great potential for orthopedic applications. Mg-based biomaterials possess many advantages over newly developed and current applied biomaterials as bone implants, such as favorable in vivo biological properties, mechanical properties and density similar to those Read More

Cardiovascular diseases represent the first cause of death in industrialized countries. To date, cardiac surgery is still considered the preferential treatment especially for those patients with severe heart failure. For these reasons, over the years the number of patents and applications in the cardiothoracic surgical area has notably improved probably than any other research field, starting from heart valves, devices and stents Read More

Experimental works in the field of reconstructive plastic surgery have been especially focused in restorative procedures based on flaps and peripheral nerve regeneration. Those involving the use of VEGF gene therapy showed generated particular interest but also many significant conclusions in both fields of reconstructive surgery which are currently introducing in the operating room. Interestingly, composite tissu Read More